Long journey for DBV peanut patch ends in rejection by FDA
DBV Technologies’ long and winding saga with the FDA has ended — for now, at least — with a CRL for their peanut allergy skin patch. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
